[Plasma catecholamine level and clinical parameters--quality criteria for premedication in childhood]

Anaesthesiologie Und Reanimation
|January 1, 1995
PubMed

Insights

Intravenous midazolam effectively reduces stress hormones and improves mask acceptance in children undergoing medical procedures. This premedication method offers superior anxiolysis compared to psychological preparation or oral promethazine.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology

Background:

  • Premedication in children aims to reduce anxiety and stress during medical procedures.
  • Objective assessment of anxiolytic efficacy is crucial for optimizing pediatric care.

Purpose of the Study:

  • To compare the anxiolytic effects of psychological preparation, intravenous midazolam, and oral promethazine in children.
  • To evaluate the impact of different premedication methods on stress hormone levels and physiological parameters.

Main Methods:

  • Plasma levels of noradrenaline and adrenaline were measured before and after premedication.
  • Heart rate, blood pressure, and behavioral responses to a face mask were documented.
  • Three groups of 16 children (aged 3-15 years) received either psychological preparation, intravenous midazolam (0.1 mg/kg), or oral promethazine (1 mg/kg).

Main Results:

  • Intravenous midazolam significantly reduced heart rate and blood pressure compared to other groups.
  • Adrenaline levels remained low post-premedication in the midazolam group, unlike other groups where levels increased.
  • Children receiving midazolam demonstrated better mask acceptance and anxiolysis.

Conclusions:

  • Intravenous midazolam is a highly effective premedication for children, reducing physiological stress markers.
  • Midazolam administration leads to superior anxiolysis and better cooperation during procedures requiring face mask use.
  • Objective measures of stress hormones and physiological signs support the efficacy of intravenous midazolam in pediatric premedication.

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...